Trinity Biotech PLC

TRIB Healthcare Medical Devices

Trinity Biotech PLC’s revenue for fiscal 2025 (year ended December 2025) was $43.8 million, down 28.9% from fiscal 2024. In the quarter to March 2026, revenue grew 43.3%, EPS grew 52.1%, free cash flow grew 75.2% and total debt rose 29.9%, each against the same quarter a year earlier. Dividend growth for five consecutive years.

8.03 0.10 +1.26%
Market cap
$5.1M
P/E
0.0×
Fwd P/E
−1.3×
Dividend yield
—
F-score
4/9
Altman Z
−2.78
Beneish M
−4.29
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Total current assets
133.49 112.59 86.66 71.39 83.30 72.69 46.67 39.04 41.12 35.90
Total non-current assets
116.10 80.38 65.00 59.68 47.10 46.21 45.44 20.39 62.17 69.26
Total Assets
249.59 192.97 151.66 131.07 130.40 118.90 92.10 59.44 103.29 105.17
Total current liabilities
25.28 21.23 17.60 19.45 27.06 100.49 17.34 15.04 32.10 141.21
Total non-current liabilities
115.59 106.55 90.00 106.91 105.56 18.72 76.94 68.35 106.38 35.94
Total liabilities
140.87 127.78 107.61 126.36 132.62 119.21 94.28 83.38 138.47 177.15
Common Equity (Total)
108.73 65.20 44.05 4.71 (2.22) (0.32) (2.18) (23.95) (35.18) (71.98)
Shareholders Equity (Total)
108.73 65.20 44.05 4.71 (2.22) (0.32) (2.18) (23.95) (35.18) (71.98)
Total Debt
93.24 93.84 82.34 102.17 101.44 99.16 72.20 65.52 98.27 135.19

Show all line items

In millions of $ except per-share values · columns are period end dates